Screening for breast cancer with mammography
59 results
1 - 59
Screening for breast cancer with mammography
Screening for breast cancer with mammography - Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk
Mammography doesn't decrease cancer-related deaths long-term- Population screening for cancer
- Switching to digital mammography for all is too costly
- Interventions for relieving the pain and discomfort of screening mammography
- Breast cancer
- Adding ultrasound to mammography increases false-positive findings without an increase in cancer detection
- European guidelines on breast cancer screening 2020
- Breast cancer screening with MRI: more false-positives, more biopsies
- Breast cancer screening benefits overrated
- Mammography identifies many women who will not benefit from treatment
- Screening mammography overdiagnoses women with breast cancer
- For women with dense breasts, supplemental screening with contrast enhanced mammography is similar to MRI (BRAID)
- Guideline: Mammography optional in women 40-49
- Small benefit to breast cancer screening for most women
- Combined ultrasound + mammogram for high-risk women increases cancer yield
- USPSTF: No routine mammography for women younger than 50 years
- Numbers to help women understand the benefits/ harms of screening mammography
- Overuse alert: Computer aid does not improve mammography accuracy
- Screening for breast cancer: False-positive rates 60% over 10 years
- Strategies for increasing the participation of women in community breast cancer screening
- Annual mammography starting at 40 doesn't lower breast CA mortality
- Overdiagnosis of breast cancer is common
- Clinical breast examination: lump, pain and benign changes
- USPSTF recommends mammography every other year for all women 40 to 74 years old
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income countries
- American College of Physicians: mammography every 2 years between the ages 50 and 74 years
- No change in mammography rates after 2009 USPSTF update
- Post-operative radiotherapy for ductal carcinoma in situ of the breast: Cochrane systematic review
- Postoperative tamoxifen for ductal carcinoma in situ
- Mobile clinics for women's and children's health
- Follow‐up strategies for women treated for early breast cancer
- Breast augmentation
- Prostate cancer
- Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations